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The expression of the core gene of two different hepatitis C virus (HCV) isolates was analyzed. In the presence of its
downstream E1 envelope protein sequence, two major core protein products with molecular masses of 21 kDa (P21) and
19 kDa (P19) and a minor protein product with molecular mass of 16 kDa (P16) were detected. In the absence of its
downstream E1 envelope protein sequence, P21 and P19 remained the major protein products expressed from the core
gene of the HCV-RH isolate, whereas P16 became the major protein product of the core gene of the HCV-1 isolate. Analysis
of the amino-terminal sequences of P21 and P16 expressed in Escherichia coli revealed that P21 and P16 were co-amino
terminal. Deletion-mapping analysis indicated that P16 lacked the carboxy-terminal sequence of P21. Immunofluorescence
analysis of the subcellular localization of different HCV core proteins indicated that P21 and P19 displayed a reticular and
punctate staining pattern typical of endoplasmic reticulum-associated proteins, while P16 was localized to the nucleus. The
distinct subcellular localization of P16 raises the possibility that P16 may have a biological function very different from
those of P21 and P19. q 1995 Academic Press, Inc.
INTRODUCTION and, thus, the core protein is expected to be 191 amino
acids in length. The core protein of this size (P21) has
Hepatitis C virus (HCV) is an enveloped, positive-
been detected in expression experiments both in vitro
stranded RNA virus with a genome size of almost 10 kb
(Hijikata et al., 1991; Lo et al., 1994) and in vivo (Harada
and belongs to the Flaviviridae family (Francki et al.,
et al., 1991). The carboxy terminus of the core protein
1991). HCV is one of the major causes of viral hepatitis
sequence contains two hydrophobic domains (Takami-
and over 50% of the patients infected with HCV become
zawa et al., 1991). The first hydrophobic domain is lo-
chronic carriers (Kuo et al., 1989). Many of these patients
cated immediately upstream of the E1 envelope protein
have chronic active hepatitis and will develop liver cirrho-
sequence and is believed to be the signal sequence
sis. This virus is also a major cause of hepatocellular
for translocation of the E1 envelope protein across the
carcinoma (Saito et al., 1990).
membrane of the endoplasmic reticulum (ER). This do-
The HCV genome has a long open reading frame
main comprises approximately the sequence from amino
which encodes a polyprotein with a length of approxi-
acid 170 to amino acid 191. The second hydrophobic
mately 3010 amino acids (Choo et al., 1991). This poly-
domain comprises approximately the sequence from
protein is processed into at least 10 distinct gene amino acid 121 to amino acid 151. In addition to P21, a
products, which are arranged in the linear order NH2-C- core protein approximately 173 amino acids in length
E1 - E2 - p7 - NS2 - NS3 - NS4A - NS4B - NS5A - NS5B - COOH (P19) has been detected (Santolini et al., 1994). This pro-
(Grakoui et al., 1993b). The C gene, which is located at tein has apparently lost most of the first hydrophobic
the amino terminus of the polyprotein sequence, en- domain located between amino acids 170 and 191. The
codes the core (capsid) protein. The sequence of the conversion of P21 to P19 in vitro requires the presence
core protein is followed by the sequences encoding E1 of microsomal membranes and is presumably mediated
and E2 envelope proteins. p7 is located at the carboxy by membrane-associated cellular enzymes (Santolini et
terminus of E2 (Lin et al., 1994). This protein is not always al., 1994). Both P21 and P19 are associated with the ER
cleaved from the E2 sequence. NS2–NS5 are nonstructu- membrane. The role of these two different core protein
ral proteins (Failla et al., 1994; Grakoui et al., 1993a; products in the assembly of the HCV virion, however,
Takamizawa et al., 1991). remains unclear.
The amino-terminal sequence of the E1 protein has In addition to P21 and P19, we have recently identified
been mapped to amino acid 192 (Hijikata et al., 1991) a third HCV core protein product approximately 16 kDa
in size (Lo et al., 1994). This protein, which we termed
P16, is produced by the core protein sequence of the1 To whom correspondence and reprint requests should be ad-
dressed. HCV-1 isolate in translation experiments in vitro. The
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synthesis of P16 was not detected when the core protein core protein coding sequence (a.a. 1–191) of the HCV-
RH and the HCV-1 isolate, respectively.sequence of another HCV isolate, HCV-RH, was used for
the in vitro translation experiments (Lo et al., 1994). Fur- pCMV-RCEb and pCMV-CCEb. The core protein cod-
ing sequence and its downstream E1 envelope proteinther analysis revealed that the synthesis of P16 was due
to a single nucleotide substitution which converted co- sequence were isolated by PCR using the sense primer
5* ACA TTT GCT TCT GAC ACA ACT GTG TTC ACT AGCdon 9 of the HCV-1 core protein sequence from an argi-
nine codon (Arg-9) to a lysine codon (Lys-9) (Lo et al., AAC CTC AAA CAG ACA CCA TGA GCA CGA AT 3* and
the antisense primers 5* TCA TTG CAG TTC AGG GC 3*1994). Since fusing a leader sequence to the 5*-end of
the HCV core protein coding sequence increases the (HCV-RH) or 5* GCT AAC AAA TCT AGA CAC AGT 3*
(HCV-1). For the HCV-RH isolate, the PCR product wassize of P16 correspondingly, P16 likely resides in the
amino terminus of the core gene sequence (Lo et al., cloned into the SmaI site of pUC18 to generate pUC-
RCEb. The HCV sequence was reisolated from pUC-1994).
In order to investigate the functions of various HCV RCEb with HindIII and EcoRI double digestion and in-
serted into the NotI–HindIII site of pRc/CMV. The re-core proteins, we have studied the expression of HCV
core proteins in CV1 cells, a cell line derived from mon- sulted plasmid pCMV-RCEb contained the entire coding
sequence of the HCV-RH core protein and its down-key kidney. Our results revealed that a small amount of
P16 can also be produced by the core gene carrying the stream E1 envelope protein from nucleotide 1 to 1292
(a.a. 1–430). For the HCV-1 isolate, the PCR product wasArg-9 codon. In addition, our results obtained from in
vitro translation experiments and from sequencing of P16 digested with XbaI and cloned directly into the HindIII
(blunt-ended)– XbaI site of pR/c-CMV. This plasmid con-and P21 expressed in Escherichia coli indicate that P16
and P21 are co-amino terminal. Our subcellular localiza- tained the entire coding sequence of the HCV-1 core
protein and its downstream E1 envelope protein fromtion experiments revealed that, in contrast to P21 and
P19, which are associated with the ER membranes, P16 nucleotide 1 to 1191 (a.a. 1–397). Both pCMV-RCEb and
pCMV-CCEb also contained partial E2 envelope proteinis a nuclear protein. This distinct subcellular localization
of P16 raises the possibility that it may have a function sequence. We have noticed in the past that the length
of the E2 sequence did not affect the expression of thedifferent from those of P21 and P19.
core protein (data not shown). In pCMV-RCEb and pCMV-
CCEb, the 5* untranslated sequence of HCV had beenMATERIALS AND METHODS
replaced with the 5* untranslated sequence of human a-
Construction of DNA plasmids
globin mRNA (Liebhaber et al., 1980). We have found that
the a-globin mRNA leader sequence could increase thepET-RC and pET-CC. The isolation of HCV-RH and
HCV-1 cDNA clones has been described previously translation efficiency of the HCV sequence both in vitro
and in vivo. This leader sequence has no effect on the(Choo et al., 1991; Lo et al., 1994). The core protein coding
sequence of either HCV-RH or HCV-1 isolate was iso- expression pattern of the core gene.
pCMV-RC151. This plasmid contained the HCV-RHlated from the cDNA clones by the polymerase chain
reaction (PCR) using the primers 5* AGA CCG TGC CAT core protein sequence from a.a. 1–151. This truncated
HCV-RH core protein sequence was isolated by PCRATG AGC ACG AAT 3* (sense) and 5* GAG TTG CGG
AAT TCT TAG GCC GAA 3* (antisense). After blunt-end- using the sense primer 5* ACA TTT GCT TCT GAC ACA
ACT GTG TTC ACT AGC AAC CTC AAA CAG ACA CCAing with the Klenow enzyme and subsequent digestion
with NdeI, the PCR product was cloned into the BamHI TGA GCA CGA AT 3* and the antisense primer 5* TGC
TCT AGA CTA CAG GGC CCT GGC AGC 3*. The PCR(blunt-ended) and NdeI site of a pET3a-derived vector
(Rosenberg et al., 1987). The resulting plasmid pET-RC product was digested with XbaI and inserted into the
HindIII (blunt-ended)– XbaI site of pRc/CMV. The 5* un-and pET-CC contained the complete core protein coding
sequence (a.a. 1–191) of the HCV-RH and the HCV-1 translated sequence of HCV in this plasmid has been
replaced with the 5* untranslated sequence of human a-isolate, respectively. All of the HCV cDNA clones derived
from PCR were sequenced to ensure that no nucleotide globin mRNA.
pCMV-RC127. This plasmid contained the HCV-RHmutations were created.
pCMV-RC and pCMV-CC. The HCV core protein coding core protein sequence from a.a. 1–127. This truncated
HCV-RH core protein sequence was isolated by PCRsequence as well as 94 nt of its upstream 5*-untranslated
sequence were isolated by PCR using the primers 5* using the sense primer 5* CGT GCC CCC GCA AGC TTG
CTA G 3* and the antisense primer 5* GTC GGC GAACGT GCC CCC GCA AGC TTG CTA G 3* (sense) and 5*
GAG TTG CGG AAT TCT TAG GCC GAA 3* (antisense). TTC TCA CGT AAG 3*. The PCR product was digested
with HindIII and inserted into the XbaI (blunt-ended) –The PCR product was blunt-ended with the Klenow frag-
ment, digested with HindIII, and inserted into the XbaI HindIII site of pRc/CMV. This plasmid contained the trun-
cated HCV-RH core protein sequence as well as 94 nu-(blunt-ended)– HindIII site of pRc/CMV vector (In-
vitrogen). pCMV-RC and pCMV-CC contained the entire cleotides of its upstream 5* untranslated sequence.
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Amino-terminal sequencing of HCV core proteins
expressed in E. coli
The E. coli BL21(DE3) cells transformed by pET-RC,
pET-CC, or the control plasmid pET3a were grown to the
stationary phase. A 5-ml culture of these stationary phase
cells was inoculated into a fresh 500-ml culture and
grown to OD 0.6. IPTG was then added to the culture to
a final concentration of 1 mM. After a further incubation FIG. 1. Expression of the HCV core gene in the presence of its
downstream E1 envelope protein gene sequence in CV1 cells. Detailsat 377C for 3 hr, the E. coli cells were pelleted by centrifu-
of the expression procedures using the T7 phage promoter and thegation. The pellet was dissolved in Laemmli buffer,
vaccinia virus carrying the T7 RNA polymerase gene are described inboiled, and loaded on an SDS–PAGE gel. After electro-
Materials and Methods. The Western blot was performed using our
phoresis, P21 and P16 core proteins were passively previous procedures (Liao and Ou, 1995). The rabbit anti-core antise-
eluted from the gel in 30 mM NH4HCO3 and 0.1% SDS. rum and the peroxidase-conjugated goat anti-rabbit were used as the
primary and the secondary antibodies, respectively. Both antibodiesThe protein was acetone precipitated with the method
were diluted 1:1000 prior to use. (A) Lane 1, cells transfected with theof Konigsberg and Henderson (1983). The sequence
HCV-1 sequence (pCMV-CCEb); lanes 2 and 3, cells transfected withanalysis was performed by Edman degradation using
the HCV-RH sequence (pCMV-RCEb); lane 4, cells transfected with the
Applied Biosystems 470A and 473A protein sequencers. control plasmid pRc/CMV. M, molecular weight markers. Lanes 2 and
The HCV core proteins prepared this way were also 3 represent two different expression experiments. The expression level
of the HCV-RH core protein was much higher in the experiment of laneused for preparation of antibodies in rabbits for Western
3 than in that of lane 2 due to a higher transfection efficiency. Thisblot analysis.
higher expression increased the signal of the 16-kDa core protein band,
which was barely detectable in lane 2 after a prolonged exposure of
the film (data not shown). (B) The HCV core gene products expressedCarboxy-terminal truncation experiments
by pCMV-RCEb (lane 1) and by pCMV-CCEb (lane 2) were run in
parallel on the gel. As shown in the figure, the P16 core protein ex-The HCV-1 core gene sequence was truncated by PCR.
pressed by both plasmids had the same electrophoretic mobility. TheThe truncation at a.a. 164 was conducted using these
sample in lane 3 was prepared from cells transfected with the control
two primers: 5* CGT GCC CCC GCA AGC TTG CTA G3* plasmid pRc/CMV.
(sense) and 5* GTT CCC GGA TCC ATA GTT CAC3*
(antisense). The truncation at a.a. 179 was conducted
using the same sense primer and the following antisense Immunofluorescence analysis
primer: 5* GCA AGA GAG GGA TCC CAG AAG GAA3*.
CV1 cells infected with the recombinant vaccinia virusSimilarly, the truncation at a.a. 193 was conducted using
and transfected with the HCV core protein expressionthe same sense primer and the following antisense
plasmid were fixed with 0207C acetone for 2 min. Theprimer: 5* GGA GTT GGA TCC TTG GTA GGC CGA3*.
rabbit anti-core, diluted 1:200 in PBS containing 1% BSA,The PCR products were inserted into the plasmid vector
0.05% sodium azide and 0.02% saponin, was used aspRc/CMV. The plasmids were linearized with BamHI and
the primary antibody. The secondary antibody used wasused for RNA synthesis using the T7 RNA polymerase.
rhodamine-conjugated goat anti-rabbit.The synthesized RNA was then translated using rabbit
reticulocytes using our previous procedures (Lo et al.,
RESULTS1994).
Expression of the HCV core proteins in CV1 cells
Expression of HCV core protein in CV1 cells
The HCV sequence containing the core gene and its
downstream E1 envelope protein gene was placed un-CV1 cells were maintained in Dulbecco’s modified Ea-
gle’s medium (DME) containing 5% fetal bovine serum der the expression control of the T7 phage promoter.
The resulting DNA plasmid was then transfected into(BSA). The cells were infected with a recombinant vac-
cinia virus carrying the T7 phage RNA polymerase gene CV1 cells which had previously been infected with re-
combinant vaccinia virus carrying the T7 phage RNA(Fuerst et al., 1986). During infection, cells were incu-
bated in DME containing 1% FBS. Two hours postinfec- polymerase gene. The expression of the core protein
was then analyzed by Western blot. As shown in Fig.tion, cells were transfected with DNA plasmids using the
DOTAP reagent (Boehringer-Mannheim) in DME con- 1A, lane 1, expression of the core gene of the HCV-1
isolate, which carried the Lys-9 codon, led to synthesistaining 5% FBS. Sixteen to 18 hr after transfection, the
cells were lysed with Laemmli buffer and the samples of a major core protein product approximately 20 kDa
and a minor core protein product 16 kDa. The 20-kDawere electrophoresed on an SDS–PAGE gel for Western
blot analysis using the rabbit antibody directed against protein band comigrated with the HCV core protein trun-
cated at amino acid 172 and is presumably mostly P19the HCV core proteins expressed in E. coli.
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envelope protein sequence, P16 became the major HCV-
1 core gene products.
Amino-terminal sequencing of HCV core proteins
We have previously found that linking a leader se-
quence to the 5*-end of the HCV-1 core gene coding
sequence would increase the size of P16 correspond-
ingly (Lo et al., 1994). This result indicated that the se-
quence of P16 most likely initiated from the 5*-end of the
FIG. 2. Expression of the HCV core gene in the absence of its down-
HCV-1 core protein coding sequence. To further investi-stream E1 envelope protein sequence in CV1 cells. Lane 1, cells
gate this possibility, we decided to directly determine thetransfected with the HCV-RH sequence (pCMV-RC); lane 2, cells
transfected with the control DNA plasmid (pRc/CMV); lane 3, cells amino-terminal sequences of both P16 and P21. In order
transfected with a truncated HCV-RH sequence with a length of 151 to obtain a sufficient amount of the core protein for the
amino acids (pCMV-RC151); lane 4, cells transfected with the HCV-1 sequencing experiment, we used E. coli as the host for
sequence (pCMV-CC).
expressing the core proteins. As shown in Fig. 3A, similar
to our previous in vitro translation results and the expres-
sion results obtained from mammalian cells (Fig. 2), a(data not shown). However, as will be discussed below,
protein slightly larger than the 18-kDa molecular weightP21 was also often detected in our expression experi-
marker was expressed from the HCV-RH core proteinments. The above result is consistent with our previous
sequence. This protein had an electrophoretic mobilityin vitro studies which indicated that P19/P21 and P16
similar to P21 synthesized in vitro (data not shown) andcould both be expressed from the HCV core gene se-
is presumed to be P21. Lack of P19 expression in E.quence in the presence of its downstream E1 envelope
coli might be due to the absence of eukaryotic enzymesprotein gene sequence (Lo et al., 1994). The expression
required for the conversion of P21 to P19 (Santolini etof the HCV-RH core gene, which carried the Arg-9 co-
al., 1994). In contrast, a 16-kDa protein (P16) was thedon, was also analyzed. As shown in Fig. 1A, lane 2,
predominant core protein expressed from the HCV-1 se-this expression led to predominant synthesis of P19/
quence. Both P21 and P16 were purified by gel electro-P21. Interestingly, a small but detectable amount of a
phoresis and subjected to amino-terminal sequencing.16-kDa protein was also detected when the expression
As shown in Table 1, the sequences of both P21 andlevel of the HCV-RH core proteins in CV1 cells was
P16 initiated from the second codon of their respectiveelevated (Fig. 1A, lane 3). This protein, which had an
electrophoretic mobility similar to that of P16, is likely
the P16 homologue (Fig. 1B). Thus, the expression of
P16 is not limited to the HCV core gene that carries
the Lys-9 codon, although apparently this Lys-9 codon
significantly enhances the expression of P16.
The expression of the HCV core gene was also ana-
lyzed in the absence of its downstream E1 envelope
protein sequence. As shown in Fig. 2, lane 1, the expres-
sion of the HCV-RH core gene by itself led to the predomi-
nant synthesis of P21 and P19. On the other hand, the
expression of the HCV-1 core gene by itself led to the
predominant synthesis of P16 (Fig. 2, lane 4). These re-
FIG. 3. Characterization of HCV core proteins. (A) Expression of
sults are consistent with our previous data obtained from HCV core proteins in E. coli. Details of the expression procedures
in vitro translation studies (Lo et al., 1994). The P16 core are described in Materials and Methods. The E. coli BL21(DE3) cells
transformed by pET-3a (lane 1), pET-RC (lane 2), or pET-CC (lane 3)protein had an electrophoretic mobility similar to that of
were grown to the stationary phase. A 5-ml culture of these stationaryan HCV-RH core protein truncated at amino acid 151
phase cells was inoculated into a fresh 500-ml culture and grown to(Fig. 1, lane 3). Thus, P16 of both the HCV-1 and HCV-
OD 0.6. At this time, IPTG was added to the culture to a final concentra-
RH isolates expressed in CV1 cells are estimated to be tion of 1 mM. After further incubation at 377C for 3 hr, the E. coli cells
about 151 amino acids. were pelleted by centrifugation. The pellet was dissolved in Laemmli
buffer and the solution boiled and loaded on an SDS–PAGE gel. TheThus, our results indicate that P16 could be expressed
gel was then stained with Coomassie blue. (B) Truncation analysis offrom the HCV-1 core gene sequence in either the ab-
the HCV-1 core protein sequence. The HCV sequence was truncatedsence or the presence of the downstream E1 envelope
at different locations by PCR. Details for HCV RNA synthesis using T7
protein sequence. In the presence of the downstream RNA polymerase and for translation using rabbit reticulocyte lysates
E1 envelope protein sequence, P21/P19 was the major have been described before (Lo et al., 1994). The arrowhead marks
the location of P16.core gene product; however, in the absence of the E1
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TABLE 1 munofluorescence staining pattern typical of ER-associ-
ated proteins. The HCV-1 core proteins also displayed aAmino-Terminal Sequences of P21 and P16 Core Proteins
similar subcellular localization when the gene was ex-Expressed in E. coli a
pressed in the presence of its downstream E1 envelope
Protein Sequenceb protein sequence (Fig. 4b). Interestingly, when the HCV-
HCV-RHc M-S-T-N-P-K-P-Q-R9-K-T-K-R-N-T-N
P21 X-T-N-P-K-P-Q-R9-K-T-K-R-N-T-N
HCV-1c M-S-T-N-P-K-P-Q-K9-K-N-K-R-N-T-N
P16 X-T-N-P-K-P-Q-K9-K-N-K-R-N-T-N
a Details of the experimental procedures are described in Materials
and Methods. The sequence analysis was performed by Edman degra-
dation using Applied Biosystems 470A and 473A protein sequencers.
b The first cycle of Edman degradation released a mixture of several
amino acids including serine. Since the identity of the first amino acid
was not clear, it was indicated with an X. Note that, based on the
sequence obtained, the X residue would correspond to the second
amino acid of the core protein coding sequence. The locations of Arg-
9 and Lys-9 were marked with the number. The single-letter code for
the amino acids is used.
c The sequences of HCV-RH and HCV-1 were deduced from their
respective nucleotide sequences.
coding sequences. The loss of the initiator methionine
residue from P21 and P16 may be due to the amino-
terminal peptidase activity present in E. coli cells.
Thus, the results shown in Table 1 are consistent with
our previous in vitro translation studies and indicate that
P21 and P16 are co-amino terminal. If this is indeed the
case, then P16 should lack the carboxy-terminal se-
quence of P21. To investigate this possibility, we have
performed the carboxy-terminal truncation experiment.
As shown in Fig. 3B, truncation of the carboxy-terminal
sequence up to amino acid 164 did not affect the expres-
sion of P16. The slower migrating protein band seen in
each lane presumably represents the full-length run-off
translation product. Thus, this result indicated that P16
indeed lacked the carboxy-terminal sequence of P21. We
have attempted to determine the carboxy-terminal se-
quence of P16 expressed in E. coli by direct sequence
analysis. Our results show heterogeneity in the sequence
(data not shown). Thus, we have not been able to localize
FIG. 4. Immunofluorescence analysis of subcellular localization of
precisely the carboxy terminus of P16. The heterogeneity HCV core proteins. CV1 cells infected with the recombinant vaccinia
of the carboxy-terminal sequence of P16 could explain virus and transfected with the HCV core protein expression plasmid
were fixed with 0207C acetone for 2 min. The rabbit anti-core serum,why the P16 core protein expressed in different systems,
diluted 1:200 in PBS containing 1% bovine serum albumin (BSA), 0.05%including the reticulocyte lysates, E. coli and CV1 cells,
sodium azide, and 0.02% saponin, was used as the primary antibody.had similar but not identical electrophoretic mobilities
The rhodamine-conjugated goat anti-rabbit antibody was used as the
(data not shown). secondary antibody. (a) Cells expressing HCV-RH core protein se-
quence in the presence of its downstream E1 envelope protein se-
Subcellular localization of the HCV core proteins quence; (b) cells expressing the HCV-1 core protein sequence in the
presence of the downstream E1 envelope protein sequence; (c) cells
P21 and P19 have previously been reported to be asso- expressing the HCV-1 core protein sequence in the absence of its
downstream E1 sequence; (d) phase-contrast picture of (c); (e) cellsciated with the membranes of the endoplasmic reticulum
expressing truncated HCV-RH core protein sequence with a length of(Santolini et al., 1994). This result was confirmed by im-
151 amino acids; (f) phase-contrast picture of (e); (g) cells expressingmunofluorescence staining experiment. As shown in Fig.
HCV-RH sequence with a length of 127 amino acids; (h) phase-contrast
4a, the core proteins of the HCV-RH isolate expressed in picture of (g). Cells expressing HCV-RH core protein sequence in the
the presence or absence of its downstream E1 envelope absence of its downstream E1 envelope protein sequence displayed
a staining pattern similar to that shown in (a).protein sequence displayed a reticular and punctate im-
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1 core gene sequence was expressed in the absence of in length, the core protein sequence between amino
acids 151 and 173 must be very important for membraneits downstream E1 envelope sequence in CV1 cells, the
core protein was localized predominantly to the nucleus, association. It is possible that this sequence is important
for exposing the second hydrophobic domain locatedwith an apparent enrichment in the nucleoli (Fig. 4c).
Since HCV-1 core gene expressed in the absence of its between amino acids 121 and 151 for P19 to become
associated with the ER membranes.downstream E1 envelope protein gene sequence will
produce predominantly P16 (Fig. 2), this result indicates It has been reported that the HCV core protein ex-
pressed in Huh-7 hepatoma cells is localized predomi-that P16 is a nuclear protein. This speculation is sup-
ported by the observation that the HCV-RH core protein nantly in the cytoplasm 2 days after DNA transfection
and in the nucleus 6 days after DNA transfection (Shihtruncated at amino acid 151 is also localized predomi-
nantly to the nucleus (Fig. 4e). Note that while P16 is also et al., 1993). By using Huh-7 cells as the host cells for
the expression experiment, we have not been able toexpressed from the HCV-1 core gene in the presence of
the E1 envelope protein sequence, no significant nuclear observe nuclear localization of the core protein of the
HCV-RH isolate even 6 days after DNA transfection. It isstaining of the core protein was detected in Fig. 4b. This
may be due to the reduced level of P16 expression in the likely that the difference in subcellular localization of the
HCV core protein observed by the two different labora-presence of the E1 protein sequence and/or the bright
cytoplasmic staining signal which obscured the nuclear tories is due to the difference of HCV isolates used in
the experiments. It will be interesting to determinecore protein signal.
As shown in Fig. 4g, the HCV-RH core protein truncated whether the nuclear core protein detected by Shih et al.
(1993) was predominantly P16.at amino acid 127 also had a similar nuclear localization
pattern. This result indicates that, if a nuclear localization The observation that P16 may be enriched in the nucle-
olus is interesting. It has been reported that the HCVsignal is present in the HCV core protein sequence, it would
likely reside upstream of amino acid 128. core protein can bind to the ribosomes (Santolini et al.,
1994). Thus, this nucleolar localization of P16, if it is
confirmed, may be due to its ability to bind to ribosomesDISCUSSION
which are assembled in the nucleolus. The biological
function of P16 remains unclear. However, its distinctIn this report, we have demonstrated that a truncated
HCV core protein of 16 kDa is produced from the HCV- localization in the nucleus and the nucleolus suggests
that it may have a biological function very different from1 core gene sequence. This core protein, which we
termed P16, is apparently co-amino terminal with the full- those of P21 and P19.
length core protein P21. A protein of a similar electropho-
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